Difficulty: Medium
Average Score: 69%
Practice
Jack is a 65-year-old man who presents to his physician for management of hyperlipidemia. His most recent lipid panel reveals an LDL cholesterol level of 165 mg/dL. His physician wishes to begin treatment to lower his LDL cholesterol levels. Which of the following therapies is the best option to lower Jack's LDL cholesterol levels?
Correct answer
D
Rationale
D' is correct because simvastatin, a statin, potently lowers LDL by inhibiting HMG-CoA reductase, per guidelines for LDL >130 mg/dL. 'A' (fenofibrate) targets TG. 'B' (colesevelam) is less potent. 'C' (niacin) mainly raises HDL. Simvastatin is first-line for LDL reduction.